Biology of Blood and Marrow Transplantation
Volume 14, Issue 2 , Pages 208-219 , February 2008

Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host Disease

  • Hildegard T. Greinix

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationCorrespondence and reprint requests: Hildegard T. GREINIX, MD, Medizinische Universitaet Wien, Klinik fuer Innere Medizin I, Knochenmarktransplantation, Waehringer Guertel 18-20 A-1090 Vienna, Austria. Phone: +43-1-40400-5706 Fax: +43-1-40400 2511.
    • ,
  • David Pohlreich

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
    • ,
  • Michal Kouba

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
    • ,
  • Ulrike Körmöczi

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
    • ,
  • Imke Lohmann

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
    • ,
  • Karin Feldmann

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
    • ,
  • Christoph Zielinski

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
    • ,
  • Winfried F. Pickl

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationWinfried F. PICKL, MD Institut fuer Immunologie, Medizinische Universitaet Wien, Borschkegasse, 8°, A-1090 Vienna, Austria, Phone: +43-1-4277-64945, Fax: +43-1-4277-9649.

References 

  1. Lee SJ, Vogelsang G, Gilman A, et al. A survey of diagnosis, management, and grading of chronic GVHD. Biol Blood Marrow Transplant. 2002;8:32–39
  2. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–956
  3. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341:14–21
  4. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant. 1990;5:209–226
  5. Storek J, Joseph A, Espino G, et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood. 2001;98:3505–3512
  6. Roberts MM, To LB, Gillis D, et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant. 1993;12:469–475
  7. Small TN, Avigan D, Dupont B, et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant. 1997;3:65–75
  8. Barrett J. Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment. Curr Opin Immunol. 2006;18:592–598
  9. Sullivan KM, Blume KG, Forman SJ, Applbaum FR. Graft versus host disease. In: Thomas'Hematopoietic Cell Transplantation. Malden, MA: Blackwell Publishers; 2004;p. 635–664
  10. Tivol E, Komorowski R, Drobyski WR. Emergent autoimmunity in graft-versus-host disease. Blood. 2005;105:4885–4891
  11. Hakim FT, Mackall CL. The immune system: effector and target of graft-versus-host disease. In:  Deeg HJ,  Burakoff SJ editor. Graft-vs. -Host Disease. New York: Marcel Dekker, Inc.; 1997;p. 257–289
  12. Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-versus host disease. Blood. 2006;108:756–762
  13. Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant. 2003;9:505–511
  14. Teshima T, Reddy P, Liu C, et al. Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood. 2003;102:429–435
  15. Kalhs P, Panzer S, Kletter K, et al. Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med. 1988;109:461–464
  16. Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003;197:939–945
  17. Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol. 2003;24:343–349
  18. Carsetti R, Rosado MM, Wardemann H. Peripheral development of B cells in mouse and man. Immunol Rev. 2004;191:179–191
  19. Mackay F, Silveira PA, Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signalling. Curr Opin Immunol. 2007;19:327–336
  20. Zinkernagel RM, Hengartner H. Protective ‘immunity’ by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called ‘immunological-memory’. Immunol Rev. 2006;211:310–319
  21. Burrows PD, Cooper MD. B cell development and differentiation. Curr Opin Immunol. 1997;9:239–244
  22. Tedder TF, Fearon DT, Gartland GL, et al. Expression of C3b receptors on human B cells and myelomonocytic cells but not natural killer cells. J Immunol. 1983;130:1668–1673
  23. Sims GP, Ettinger R, Shirota Y, et al. Identification and characterization of circulating human transitional B cells. Blood. 2005;105:4390–4398
  24. Warnatz K, Wehr C, Drager R, et al. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology. 2002;206:502–513
  25. Malaspina A, Moir S, Ho J, et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A. 2006;103:2262–2267
  26. Maurer D, Fischer GF, Fae I, et al. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol. 1992;148:3700–3705
  27. Maurer D, Holter W, Majdic O, Fischer GF, Knapp W. CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol. 1990;20:2679–2684
  28. Cancer Therapy Evaluation Program: Common Toxicity Criteria 1999: Bethesda, MD: National Cancer Institute (Accessed July 17, 2006, at http://ctep.cancer.gov/forms/CTCManual_v4_10-4-99.pdf).
  29. Pavletic SZ, Lee SJ, Socie G, et al. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant. 2006;645–651
  30. Rizzo JD, Wingard JR, Tichelli A, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006;12:138–151
  31. Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant. 2006;12:375–396
  32. Keil F, Kalhs P, Chen X, et al. Hematopoietic donor chimerism and graft-versusmyeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation. Ann Hematol. 1999;78:376–379
  33. Perreault C, Giasson M, Gyger M, et al. Serum immunoglobulin levels following allogeneic bone marrow transplantation. Blut. 1985;51:137–142
  34. Storek J, Espino G, Dawson MA, et al. Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood. 2000;96:3290–3293
  35. Storek J, Ferrara S, Ku N, et al. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?. Bone Marrow Transplant. 1993;12:387–398
  36. Leitenberg D, Rappeport JM, Smith BR. B cell precursor bone marrow reconstitution after bone marrow transplantation. Am J Clin Pathol. 1994;102:231–236
  37. Storek J, Witherspoon RP, Webb D, et al. Lack of B cells in marrow transplant recipients with chronic graft-versus-host disease. Am J Hematol. 1996;52:82–89
  38. Sanchez-Garcia J, Serrano J, Gomez P, et al. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia. Haematologica. 2006;91:340–347
  39. Cuss AK, Avery DT, Cannons JL, et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol. 2006;176:1506–1516
  40. Avanzini MA, Locatelli F, Dos Santos C, et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp Hematol. 2005;33:480–486
  41. Warnatz K, Denz A, Drager R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99:1544–1551
  42. Korthauer U, Graf D, Mages HW, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:539–541
  43. errari S, Giliani S, Insalaco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A. 2001;98:12614–12619
  44. Endres R, Alimzhanov MB, Plitz T, et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med. 1999;189:159–168
  45. Han S, Hathcock K, Zheng B, et al. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol. 1995;155:556–567
  46. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261–268
  47. Malaspina A, Moir S, Chaitt DG, et al. Idiopathic CD4+ T lymphoctopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood. 2007;109:2086–2088
  48. Rosenberg SA, Sportes C, Ahmadzadeh M, et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ but a relative decrease of CD4+ T-regulatory cells. J Immunother. 2006;29(3):13–319
  49. Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science. 2003;301:1374–1377
  50. Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000;404:995–999
  51. Zhang M, Ko KH, Lam QL, et al. Expression and function of TNF family member B cell activating factor in the development of autoimmune arthritis. Int Immunol. 2005;17:1081–1092
  52. Yurasov S, Wardemann H, Hammersen J, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med. 2005;201:703–711
  53. Samuels J, Ng YS, Coupillaud C, et al. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med. 2005;201:1659–1667
  54. Schultz KR, Miklos DB, Fowler D, et al. Toward biomarkers for chronic graft-versus host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant. 2006;12:126–137

PII: S1083-8791(07)00539-3

doi: 10.1016/j.bbmt.2007.10.009

Biology of Blood and Marrow Transplantation
Volume 14, Issue 2 , Pages 208-219 , February 2008

Article Tools

* Image Usage & Resolution